Transgenic mice expressing atrial natriuretic factor-SV40 T-antigen fusion genes (ANF-TAG) developed cardiac tumors asymmetrically in the right atrium. Features associated with cardiac failure, including increased plasma creatine kinase activity (MM and MB) and ventricular dysrhythmias, also were associated with atrial tumor growth. These atrial tumors were able to grow at histocompatible sites (subcutaneously in syngeneic animals) for protracted periods of time yielding a series of transplantable atrial tumor lineages. The transplantable tumors displayed several cardiac-specific characteristics, such as endogenous electrical activity and expression of cardiac-specific proteins. These transplantable atrial tumors constitute a novel experimental resource for developing cell lines which display an adult cardiac phenotype.
INTRODUCTION
Adult mammalian cardiac muscle is incapable of growth by proliferation ofexisting muscle cells (12) . This inability to proliferate has important implications for individuals recovering from myocardial infarcts and related trauma. The failure of adult cardiomyocytes to regenerate following trauma results in the replacement of functional muscle with electrically inactive fibrous (scar) tissue which is unable to contract. Such disruptions in cardiac function also enhance the risk of further disease in such individuals, as for example lethal dysrhythmias.
The induction ofcontrolled myocardial growth in vivo would have profound implications for the treatment of heart disease. Such regeneration therapies require that the molecular controls which regulate growth and development of the heart be identified. However, we have at hand little information about mechanisms regulating the cardiomyocyte cell cycle. It is reasonable to expect that ubiquitious mechanisms, identified in the past few years using various eukaryotic tissue culture cells, will contribute to such regulation. Nevertheless, we may anticipate that tissue-specific factors will also participate. Given the unique properties of cardiomyocytes, cardiac-specific regulatory factors analogous to those described for skeletal muscle (5) should constitute an important focus of future work. Unfortunately, such studies are presently hampered by the absence of experimental systems (cell lines) analogous to those which have permitted the convenient study ofother tissues. Conditions which allow cultured adult cardiomyocytes to survive for periods of up to several months have been defined (4, 7) , but these cells do not proliferate and do not survive passaging. Similar results have been obtained with cardiomyocytes isolated from neonatal animals (7) . Accordingly, many studies on cardiomyocyte proliferation and differentiation have focused on describing the tissue-specific expression of proto-oncogenes and other gene products during embryonic development (6) .
Studies of mammalian biology have been aided in the past decade by the development oftechnology for introducing new genetic information into the germ line of organisms (2, 3, 9, 11, 15) . The foreign DNA, once integrated, is retained and transmitted to subsequent generations in a Mendelian fashion. This method of gene transfer offers advantages for the study of complex biological problems at the organismallevel in that the consequences of a single, defined genetic trait can be followed in vivo. To elucidate the molecular signals by which cardiomyocyte proliferation can be controlled, we have generated several lineages oftransgenic mice that express the SV40 T-antigen (T-Ag) oncogene in atrial tissue (8) . Expression of this transforming gene in the cardiomyocyte induces cell division leading to the for-464 mati on of atrial tumors. The present report summarizes our recent investigations of a series of transplantable atrial tumor lineages which are composed predominantly of well-differentiated cardiomyocytes.
METHODS

Transplantation of Transgenic Atrial Tumors
The generation of ANF-TAG transgenic mice has been previously described (8) . Donor transgenic atrial tissue was rinsed in sterile saline, minced, and passed through a 14-gauge needle several times to dissociate the tissue. Anesthetized (2.5% avertin, 0.015 ml/g body weight) female syngeneic (B6D2/ FI, Jackson Laboratory) mice were injected subcutaneously with 0.5 ml ofthe dissociated transgenic tissue. Mice were examined periodically for evidence oftumor growth. These experiments were performed in accordance with appropriate federal and institutional guidelines.
Electrocardiographic Analysis
The electrical activity in transgenic and transplant recipients was recorded from surface electrodes placed in standard lead I and on opposing sides of the subcutaneous tumors, respectively. The blood pressure pulse traces were obtained from a pressure transducer placed on the tail ofthe mouse. For each experiment, animals were anesthetized with avertin and warmed to 39°C to facilitate pulse recordings. Electrical activity of freshly explanted tissues was recorded from electrodes placed in a tissue bath containing 37°C M2 media (II). No background activity was detected when tissues were removed from the bath at the instrument sensitivity used for these recordings. All traces were recorded with a Narco Biosystems Mark III physiograph. Some traces were recorded digitally at 2,000 samples/second on a Zeos 286 computer using a Coulbourn AID converter. Digitized data were analyzed using CODAS and NCSS 5.0 programs.
RNA Hybridization Analysis
Tissues were homogenized in urea/phenol, extracted with phenol and chloroform, and total RNA purified by centrifugation through CsCI as described by Sambrook et al (16) . RNA was denatured with glyoxal, separated on agarose (1.2%), and transferred to Genescreen (20) . The RNA was hybridized to a nick-translated cDNA probe specific for ANF under the conditions described. Equivalent amounts of RNA were verified by ultraviolet shadowing.
Synthesis ofPro-ANF by Atrial Tumors
Explants of normal atria and atrial tumors were incubated in DMEM plus pSS]-methionine for 3 hr.
The tissue was rinsed in PBS and the tissue homogenized in 50 mM Tris, pH 8.0, 5 mM MgCI 2 , I mM CaCI 2 , 10 rnsr dithiothreitol, and 1% Nonidet P-40. The debris was removed by centrifugation and protein in the supernatant was measured using a commercial assay (Bio-Rad) with bovine serum albumin as an external reference standard. Tissue extract protein (0.1 mg) was incubated with a polyclonal anti-ANF serum (Peninsula, #9103) and the resulting immunocomplexes precipitated with protein-A sepharose under conditions previously described (10) . The resulting immunoprecipitated proteins were separated electrophoretically on a 5/10% polyacrylamide gel under denaturing conditions. The gel was incubated with PPO, dried, and exposed to x-ray film at -70°C.
Creatine Kinase Isozyme Analysis
Blood was obtained from the orbital sinus of anesthetized animals. Plasma prepared by centrifugation was separated electrophoretically on a 1% agarose gel film (Electrotrace special film, Coming) and enzyme activity detected using a commercial kit (Sigma Diagnostics 715-EP).
Phospholipid Analysis
Lipids were extracted from tissues (1) and analyzed on silica gel G plates using a solvent system of chloroform:methanol:water (65:35:7). RESULTS We developed transgenic mice in which expression of T-Ag was targeted to the cardiac atria using the atrial natriuretic factor promoter. Adult transgenic animals harboring this fusion gene (designated ANF-TAG) express T-Ag in both atria. Expression of the oncoprotein in these animals results in unilateral right atrial hyperplasia. Electrocardiographic (ECG) analysis ofANF-TAG mice previously demonstrated a progressive disruption of the normal depolarization pattern which was proportional to hyperplastic atrial mass (8) . The voltage of such disruptive atrial depolarizations increases with atrial tumor growth. Moreover, these depolarizations can interfere with ventricular depolarizations and presumably cardiac performance. In anesthetized nontransgenic mice, heart rate is maintained within a very narrow range ( Whether the creatine kinase leaks into the bloodstream from the atrial tumors per se or from nontumorous heart tissue, secondary to tumor growth, remains unclear.
The differential hyperplastic response ofright and left atrial cardiomyocytes to T-Ag is most likely a result of asymmetrical expression ofgenes (e.g., proto-oncogenes, tumor suppressors, or progression factors) within cardiac tissue. This hypothesis is supported by the observation that when prehyperplastic neonatal transgenic atria were transplanted to a physiologically neutral environment (i.e., subcutaneously in nude mice), only transgenic right atria proliferated (17) . Therefore, it is unlikely that the unilateral right atrial hyperplasia observed in the ANF-TAG mice is a trivial consequence related to environmental cues which differ between the atria. The tumorigenic capacity of the hyperplastic right atria was also demonstrated in histocompatible syngeneic animals. Injection of minced transgenic atria subcutaneously into numerous mice yielded tumors composed of well-differentiatedcardiomyocytes ( Fig.  3 ). Subsequent passage of these tumors yielded tumors with enhanced growth properties as assessed in vivo and in culture (19) . Analysis of tumors by a variety of molecular, biochemical, histological, and electrophysiological criteria are consistent with the concept that the proliferating atrial tumor cells are A I~' \ i oJV~~I ; , vv. Ĩi ( , i f l r / f r 1: r . NJNl l/ V" , \ \ \ Nl \ I · I I I ;;
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------~-'\..<~Ĩ sec. . The blood pressure pulse traces in channel II were obtained from a pressure transducer placed on the tail of the mouse, and were recorded simultaneously with the traces in 1 and III. ECG traces in channel III were recorded with surface electrodes placed on the limbs of the mouse. Note the concordance of ventricular depolarizations (III) and the ventricular contractions detected by pulse pressure (II), as well as the independent dysrhythmic electrical activity generated by the transplanted tumors (I). Note also the relative difference voltage between the transplantable tumors and the normal mouse in channell traces; all ECG traces were recorded at identical instrument sensitivities. D) Electrical activity of explanted normal heart (I) and transplanted atrial tumor (II) in vitro. Explanted tissues were placed in pre-warmed M2 media (11) and ECG traces were recorded from electrodes placed in the bath vessel. No background activity was detected when the tissue was removed from the bath at the instrument sensitivity used for these recordings. E) ECG traces from a mouse with a solid mammary tumor. ECG traces in channell were recorded from surface electrodes placed on opposing sides ofthe mammary tumor, while those in channel II were from limb electrodes. a, b, and c reflect 5 x step increases in instrument sensitivity; the sensitivity in a was identical to that used to record the TSP tumor traces shown above. At higher sensitivity, faint electrical activity coincident with the host's heart is detected. maintaining a highly differentiated cardiomyocyte phenotype (19) . Preliminary qualitative analysis of tumor phospholipids by thin layer chromatography has indicated that the transplantable tumors contain the major phospholipids present in normal cardiac tissue, such as phosphatidylcholine, phosphatidylethanolamine, cardiolipin, and sphingomyelin. In addition, the plasmalogen content of phosphatidylcholine and phosphatidylethanolamine was not appreciably different between the transplant tumors and normal cardiac ventricular tissue. However, cholesterol was increased in the primary and transplant tumors compared to normal cardiac (ventricular) tissue.
When ECG leads were placed across the transplant tumors, an abnormal arrhythmic electrical activity was detected which was independent of the host's cardiac activity (Fig. 4A, B) . ECG leads positioned similarly in normal mice detected only a faint rhythmic activity coinciding exactly with that recorded with limb electrodes (Fig. 4C ). Moreover, after surgical excision of 90% of the tumor mass the abnormal electrical activity was essentially elirninated, and faint rhythmic activity corresponding to the host heart was again detected (not shown). Together, these observations indicate that the transplantable atrial tumors have retained at least some degree of spontaneous electrical activity. This hypothesis was further substantiated by examining normal hearts and explanted tumors in vitro; both tissues exhibited spontaneous electrical activity in Krebs-Ringers bath perfusions (Fig. 40 ). Finally, ECG leads placed across a spontaneous adenocarcinoma ( Fig. 4E) only generated traces consistent with normal cardiac activity, arguing that the abnormal electrical activity observed in the transplant recipients was generated by tumors per se, rather than as an artifact resulting from the presence of a large tumor mass. Further analysis ofthe expression ofadditional cardiac determinants at either the protein or RNA level revealed few differences between normal cardiac tissue, the primary atrial tumors, and the subcutaneous transplant tumors (19) .
Given the vast 100-fold increase in atrial tumor mass and the fact that the atria are the predominant site of ANF synthesis, it was reasonable to expect that the plasma concentration ofthe ANF hormone would be increased in the transgenic mice. In fact, transgenic mice bearing atrial tumors have about a 2-fold increase in plasma immunoreactive ANF (data not shown). Given that the increase in hormone concentration was 2 orders ofmagnitude lower than the increase in atrial mass in the transgenic animals, we suspected that the synthesis of ANF by the atrial tumors was somehow impaired. Direct evidence for such down-regulation of ANF expression was obtained by two independent methods. Atrial tumor tissue synthesized and stored much less of the ANF prohormone ( Fig. 5 ) and also contained less ANF mRNA (Fig. 6 ) than normal atrial tissue. The consequences of elevated concentrations of plasma ANF on the physiology of the ANF-TAG mice has not been investigated due to the caveat of the cardiac tumors. However, we have recently described transgenic mice which express the ANF gene in the liver (18) . The hepatic ANF expression induces a profound hypotension in the absence of any cardiac tumorigenesis.
DISCUSSION
The present study shows that atrial cardiomyocytes can be transformed by SV-40 T-antigen, resulting in the formation of tumors which maintain a rather surprisingly high degree of differentiated cardiac functions. Specifically, these T-Ag transformed cardiomyocytes appear to retain spontaneous electrical activity which can be detected within the tumors. In addition, the lipid constituents ofthe tumors are not appreciably different from normal cardiac tissue. However, both pro-ANF biosynthesis and steady-state ANF mRNA expression are reduced in the tumors as compared to normal atria.
The consequences of atrial tumor growth and the tumor-associated conduction anomalies have some similarities to other cardiac pathologies, although the precise etiologies are invariably different. Recently, we have studied individual atrial tumor cells to determine ifthe pathological perturbations in cardiac conduction in the transgenic atria have a basis at the cellular and molecular level. Several electrophysiological properties, such as the resting membrane potential, action potential waveform, and automaticity, have been examined as atrial hyperplasia proceeds. Evidence acquired to date indicates that atrial hyperplasia is accompanied by the formation of multifocal pacemakers (Dresdner et al, unpublished observations). Multifocal pacemakers are responsible for a significant portion of cardiac dysrhythmias in humans.
The disturbances within the atrial conduction system in the transgenic animals can interfere with the ventricular conduction system. Such ventricular dysrhythmias lead to perturbations in cardiac contraction as revealed indirectly by recordings of pulsatile arterial pressure (8) . These conduction and contraction defects presumably reduce cardiac output and efficiency, eventually contributing to premature death in the transgenic mice. Premature death, imposed of necessity by the site of tumor formation, restricts temporally the analysis of atrial tumorigenesis, particularly regarding genetic events secondary to transgene expression (13, 14) . To circumvent such temporal constraints, we developed a series of transplantable atrial tumor lineages in both immunodeficient (17) and syngeneic animals. The significant observation of these studies is that the atrial tumor tissue can proliferate over protracted time periods at ectopic sites without losing a variety of highly characteristic cardiac phenotypes (17, 19) . This technique should find general utility in studies with other rare cell types or, as is the case for cardiomyocytes, abundant cell types which have proven difficult to establish in tissue culture.
The unique experimental resources provided by our series of transplantable atrial tumors can be exploited to enhance our understanding of cardiac cell biology and heart development. For instance, studies ofthe interaction between the transplanted atrial tumors and the vascular system of the host may shed light on the molecular mechanisms underlying cardiac angiongenesis. Indeed, preliminary evidence suggests that these tumors synthesize mRNA coding for peptides which can exert vasoactive effects in certain vascular beds (Steinhelper, unpublished observations) . Finally, the rapid proliferation of the cells constituting these transplantable atrial tumors, coupled with their well-developed cardiornyocyte phenotype, suggests that they may prove to be an excellent substrate for deriving cardiomyocyte cell lines.
